20/20 Biolabs, Inc. (AIDX)

CIK 1139685 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for 20/20 Biolabs, Inc..

Recent SEC filings

FiledFormAccession number
Sep 10, 20268-K0001213900-26-098792
Sep 2, 20268-K0001213900-26-096743
Aug 19, 2026DEFA14A0001213900-26-091729
Aug 19, 20268-K0001213900-26-091438
Aug 17, 2026424B30001213900-26-090758
Aug 17, 2026424B30001213900-26-090765
Aug 17, 20268-K0001213900-26-090746
Aug 14, 202610-Q0001213900-26-090042
Aug 5, 20268-K0001213900-26-085514
Jul 22, 20268-K0001213900-26-080432
Jul 1, 20268-K0001213900-26-074182
Jun 23, 2026DEF 14A0001213900-26-071172
Jun 23, 2026DEFA14A0001213900-26-071173
Jun 1, 2026PRE 14A0001213900-26-063543
May 26, 20268-K0001213900-26-061039
May 21, 2026424B30001213900-26-060045
May 21, 2026424B30001213900-26-060048
May 20, 20268-K0001213900-26-059526
May 20, 202610-Q0001213900-26-059542
May 15, 2026NT 10-Q0001213900-26-057812
Apr 28, 20268-K0001213900-26-048257
Apr 28, 2026424B30001213900-26-048270
Apr 28, 2026424B30001213900-26-048269
Apr 13, 2026424B30001213900-26-043009
Apr 13, 2026424B30001213900-26-043007